TREAT-NMD is a network for the neuromuscular field that provides an infrastructure to ensure that the most promising new therapies reach patients as quickly as possible. Enabling global collaboration promotes the sharing of knowledge and skills, which we believe will speed up the delivery of successful treatment. By supporting the work of the TREAT-NMD Alliance you can help us advance research which works in partnership with institutions across the world.

 

This is what some of our partners say about TREAT-NMD:

 

"By acting as a catalyst in developing standars of care, advancing clincal research, providing expertise in outcome meausre development and leading in the creation of national patient registries, TREAT-NMD is a key partner in the development of innovative treatments." (Allen Reha, PTC Therapeutics)   

 

“Parent Project onlus is a patients’ organization based in Italy focused on DMD and BMD.

TREAT NMD Alliance has been crucial for development and promotion of standards of care, highlighting the importance of collaboration between patient organizations, researchers, clinicians and companies. Above all, it has been a catalysis for the creation of National Registries and for their global harmonization, which has been essential for the development of clinical trials.

For all these reasons it is important to support TREAT NMD Alliance’s work, because there is still much to be done.” ( Filippo Buccella, Parent project Onlus.)

 

If you would like to discuss supporting a specific project then please contact TREAT-NMD manager Dr Stephen Lynn stephen.lynn@newcastle.ac.uk or chair of the Alliance Professor Hanns Lochmuller hanns.lochmuller@ncl.ac.uk